Urology CME

Credits: 0.70 CME
Purdue University
Changing the Treatment Story With Hormonal Therapy in Prostate Cancer: Challenges and Opportunities for Improving Care Across Disease Settings
Neal D. Shore, MD, FACS
December 30, 2020
Credits: 1.00 CME / MOC
Penn State College of Medicine
Understanding the Evolving Treatment Landscape in Prostate Cancer: How to Leverage the Latest Advances and Strategies to Optimize Patient Outcomes
William K. Oh, MD
December 22, 2020
Credits: 1.00 CME / MOC
Penn State College of Medicine
Evidence and Insights on Innovative Treatment for Bladder Cancer: Clinical Breakthroughs From Targeted and Immune Options to Antibodies and Gene Therapy
Arjun Balar, MD
July 27, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Targeting DNA Repair Defects Through PARP Inhibition in Prostate Cancer: Rationale, Evidence, and Clinical Implications
Emmanuel S. Antonarakis, MD
July 22, 2020
Credits: 1.00 CME / MOC
Penn State College of Medicine
How I Think, How I Treat: Learning to Navigate the Modern Prostate Cancer Landscape
William K. Oh, MD
July 8, 2020
Credits: 0.50 CME / MOC
Penn State College of Medicine
Innovative Treatments for Bladder Cancer: Thoughts From the Chair
Arjun Balar, MD
June 22, 2020
Credits: 0.50 CME / MOC
Penn State College of Medicine
Chair’s Take on Innovation in Prostate Cancer: Thoughts on New Evidence
William K. Oh, MD
June 22, 2020
Credits: 1.50 CME
Purdue University College of Pharmacy
Mapping the Pathways to Better Patient Outcomes in Prostate Cancer: Personal Insights and Guidance From the Patient CaseBook
William K. Oh, MD
March 18, 2020
Credits: 1.50 CME / MOC
Penn State College of Medicine
Raising the Bar With Innovative Therapy for Bladder Cancer: Insights on Clinical Decision-Making in the New Era of Care
Arjun Balar, MD
March 17, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Penn State College of Medicine
Advancing Bladder Cancer Care With Novel Therapeutics: Where We Are Headed With Immunotherapy, Targeted, and Antibody Options
Arjun Balar, MD
March 10, 2020